EasyPA, Inc.

EasyPA is a healthcare technology company offering an AI-powered platform that automates prior authorization workflows for medical practices. The company was founded by physicians Dr. Paola Ballester (CEO, a Medical Director of Utilization Management), Dr. Ralph Martello (CPO/COO, a board-certified pediatric hospitalist), and Alex Vega (CTO, a senior AI software engineer). The platform integrates with 10+ EHR systems and connects to over 900 payers.

The company reports a 90%+ first-pass approval rate and processes prior authorizations in under five minutes on average. EasyPA supports multiple medical specialties including cardiology, mental health, neurology, and rheumatology. The platform is built to comply with the CMS 2026 electronic prior authorization mandate requiring API-based submissions by January 2027.

EasyPA maintains SOC 2 Type I certification and HIPAA compliance with AES-256 encryption, multi-factor authentication, and BAA agreements. The platform is hosted on AWS infrastructure with 99.9% uptime SLA and 24/7 security monitoring.

EasyPA is positioned for medical practices seeking rapid prior authorization automation with minimal workflow disruption, particularly those facing CMS 2026 compliance deadlines. The physician-led founding team brings direct clinical experience to product development, potentially resulting in better understanding of practitioner needs.

Organizations should expect EHR integration across major platforms, payer connectivity spanning 900+ insurers, and compliance infrastructure including HIPAA and SOC 2 certifications. The platform appears best suited for practices prioritizing speed-to-value and CMS mandate preparation over enterprises requiring extensive customization.

EasyPA operates exclusively in healthcare, focusing specifically on prior authorization automation for medical practices. The platform addresses specialty-specific requirements for cardiology (cardiac imaging, PCSK9 inhibitors, device implants), mental health (addressing 85% higher denial rates in behavioral health), neurology (MS drugs, migraine biologics, MRI authorizations), and rheumatology (biologics and infusion therapy).

The company maintains healthcare-specific compliance including HIPAA with BAA agreements, SOC 2 Type I certification, and CMS 2026 readiness for the January 2027 electronic prior authorization mandate. Infrastructure includes AWS hosting with healthcare-grade encryption and security monitoring.

Small to mid-sized medical practices with 5-25 providers processing high volumes of prior authorizations (20+ per provider monthly), particularly in specialties with complex authorization requirements. Organizations preparing for CMS 2026 electronic prior authorization mandates who need rapid deployment and EHR integration without extensive IT resources.